A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Effect Of Food On The Bioavailability Of Palbociclib
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2017
Price : $35 *
At a glance
- Drugs Palbociclib (Primary)
- Indications Breast cancer; Colorectal cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Multiple myeloma
- Focus Pharmacokinetics
- Sponsors Pfizer
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2013 Indications from RDI profile.
- 31 Jul 2013 New trial record